Oncology Ablation Market by Product Type and Application- Global Industry Analysis & Forecast to 2027
Published On : September 2020 Pages : 157 Category: Pharma & Healthcare Report Code : HC0912891
Oncology Ablation Market By Product Type (Radiofrequency Ablation (RFA), Microwave Ablation (MWA) and Application (Liver, Prostate, Other)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Oncology Ablation Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Oncology Ablation is anelectro-cautery technique that has emerged as the frontrunner among the many choices for local, minimally invasive tissue ablation.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Oncology Ablation Marketand estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Philips
- Biomedical
- Medtronic
- AngioDynamics
- Medtronic
- Ethicon
- ZenoMed
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Oncology Ablation Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Radiofrequency Ablation (RFA)
o Microwave Ablation (MWA)
· Oncology Ablation Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Liver
o Prostate
o Other
· Oncology Ablation Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Philips
o Biomedical
o Medtronic
o AngioDynamics
o Medtronic
o Ethicon
· Oncology Ablation Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Oncology Ablation Market , By Country
o U.S. Oncology Ablation Market
o Canada Oncology Ablation Market
o Mexico Oncology Ablation Market
o Europe
§ Europe Oncology Ablation Market , By Country
o UK Oncology Ablation Market
o Germany Oncology Ablation Market
o France Oncology Ablation Market
o Russia Oncology Ablation Market
o Italy Oncology Ablation Market
o Rest of Europe Oncology Ablation Market
o Asia-Pacific
§ Asia-Pacific Oncology Ablation Market , By Country
o China Oncology Ablation Market
o Japan Oncology Ablation Market
o South Korea Oncology Ablation Market
o India Oncology Ablation Market
o Southeast Asia Oncology Ablation Market
o Rest of Asia-Pacific Oncology Ablation Market
o South America
§ South America Oncology Ablation Market
o Brazil Oncology Ablation Market
o Argentina Oncology Ablation Market
o Columbia Oncology Ablation Market
o Rest of South America Oncology Ablation Market
o Middle East and Africa
§ Middle East and Africa Oncology Ablation Market
o Saudi Arabia Oncology Ablation Market
o UAE Oncology Ablation Market
o Egypt Oncology Ablation Market
o Nigeria Oncology Ablation Market
o South Africa Oncology Ablation Market
o TurkeyOncology Ablation Market
o Rest of MEA Oncology Ablation Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Oncology Ablation Market, By Product Type
5.1. Introduction
5.2. Global Oncology Ablation Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Oncology Ablation Revenue and Revenue Share by Product Type (2017-2021)
5.3. Radiofrequency Ablation (RFA)
5.3.1. Global Radiofrequency Ablation (RFA) Revenue and Growth Rate (2017-2021)
5.4. Microwave Ablation (MWA)
5.4.1. Global Microwave Ablation (MWA) Revenue and Growth Rate (2017-2021)
6. Oncology Ablation Market, By Applications
6.1. Introduction
6.2. Global Oncology Ablation Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Oncology Ablation Revenue and Revenue Share by Applications (2017-2021)
6.3. Liver
6.3.1. Global Liver Revenue and Growth Rate (2017-2021)
6.4. Prostate
6.4.1. Global Prostate Revenue and Growth Rate (2017-2021)
6.5. Other
6.5.1. Global Other Revenue and Growth Rate (2017-2021)
7. Oncology Ablation Market, By Region
7.1. Introduction
7.2. Global Oncology Ablation Revenue and Market Share by Regions
7.2.1. Global Oncology Ablation Revenue by Regions (2017-2021)
7.3. North America Oncology Ablation by Countries
7.3.1. North America Oncology Ablation Revenue and Growth Rate (2017-2021)
7.3.2. North America Oncology Ablation Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Oncology Ablation by Countries
7.4.1. Europe Oncology Ablation Revenue and Growth Rate (2017-2021)
7.4.2. Europe Oncology Ablation Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Oncology Ablation by Countries
7.5.1. Asia-Pacific Oncology Ablation Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Oncology Ablation Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Oncology Ablation by Countries
7.6.1. South America Oncology Ablation Revenue and Growth Rate (2017-2021)
7.6.2. South America Oncology Ablation Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Oncology Ablation by Countries
7.7.1. Middle East and Africa Oncology Ablation Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Oncology Ablation Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Philips
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Biomedical
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Medtronic
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. AngioDynamics
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Medtronic
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Ethicon
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. ZenoMed
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
9. Oncology Ablation Market Forecast (2022-2027)
9.1. Global Oncology Ablation Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Oncology Ablation Market Forecast by Regions (2022-2027)
9.2.1. North America Oncology Ablation Market Forecast (2022-2027)
9.2.1.1. United States Oncology Ablation Market Forecast (2022-2027)
9.2.1.2. Canada Oncology Ablation Market Forecast (2022-2027)
9.2.1.3. Mexico Oncology Ablation Market Forecast (2022-2027)
9.2.2. Europe Oncology Ablation Market Forecast (2022-2027)
9.2.2.1. Germany Oncology Ablation Market Forecast (2022-2027)
9.2.2.2. France Oncology Ablation Market Forecast (2022-2027)
9.2.2.3. UK Oncology Ablation Market Forecast (2022-2027)
9.2.2.4. Russia Oncology Ablation Market Forecast (2022-2027)
9.2.2.5. Italy Oncology Ablation Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Oncology Ablation Market Forecast (2022-2027)
9.2.3. Asia-Pacific Oncology Ablation Market Forecast (2022-2027)
9.2.3.1. China Oncology Ablation Market Forecast (2022-2027)
9.2.3.2. Japan Oncology Ablation Market Forecast (2022-2027)
9.2.3.3. Korea Oncology Ablation Market Forecast (2022-2027)
9.2.3.4. India Oncology Ablation Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Oncology Ablation Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Oncology Ablation Market Forecast (2022-2027)
9.2.4. South America Oncology Ablation Market Forecast (2022-2027)
9.2.4.1. Brazil Oncology Ablation Market Forecast (2022-2027)
9.2.4.2. Argentina Oncology Ablation Market Forecast (2022-2027)
9.2.4.3. Columbia Oncology Ablation Market Forecast (2022-2027)
9.2.4.4. Rest of South America Oncology Ablation Market Forecast (2022-2027)
9.2.5. Middle East and Africa Oncology Ablation Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Oncology Ablation Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Oncology Ablation Market Forecast (2022-2027)
9.2.5.3. Egypt Oncology Ablation Market Forecast (2022-2027)
9.2.5.4. Nigeria Oncology Ablation Market Forecast (2022-2027)
9.2.5.5. South Africa Oncology Ablation Market Forecast (2022-2027)
9.2.5.6. Turkey Oncology Ablation Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Oncology Ablation Market Forecast (2022-2027)
9.3. Oncology Ablation Market Forecast by Product Type (2022-2027)
9.3.1. Oncology Ablation Forecast by Product Type (2022-2027)
9.3.2. Oncology Ablation Market Share Forecast by Product Type (2022-2027)
9.4. Oncology Ablation Market Forecast by Applications (2022-2027)
9.4.1. Oncology Ablation Forecast by Applications (2022-2027)
9.4.2. Oncology Ablation Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Oncology Ablation Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Oncology Ablation Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Radiofrequency Ablation (RFA) Revenue and Growth Rate (2017-2019)
Figure Global Microwave Ablation (MWA) Revenue and Growth Rate (2017-2019)
Table Global Oncology Ablation Revenue and Revenue Share by Applications (2017-2019)
Figure Global Liver Revenue and Growth Rate (2017-2019)
Figure Global Prostate Revenue and Growth Rate (2017-2019)
Figure Global Other Revenue and Growth Rate (2017-2019)
Table Global Oncology Ablation Revenue by Regions (2017-2019)
Figure North America Oncology Ablation Growth Rate (2017-2019)
Figure North America Oncology Ablation Revenue and Growth Rate (2017-2019)
Figure North America Oncology Ablation by Countries (2017-2019)
Figure North America Oncology Ablation Revenue (Million USD) by Countries (2017-2019)
Figure United States Oncology Ablation Growth Rate (2017-2019)
Figure United States Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Oncology Ablation Growth Rate (2017-2019)
Figure Canada Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Oncology Ablation Growth Rate (2017-2019)
Figure Mexico Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Oncology Ablation Growth Rate (2017-2019)
Figure Europe Oncology Ablation Revenue and Growth Rate (2017-2019)
Figure Europe Oncology Ablation by Countries (2017-2019)
Figure Europe Oncology Ablation Revenue (Million USD) by Countries (2017-2019)
Figure Germany Oncology Ablation Growth Rate (2017-2019)
Figure Germany Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Oncology Ablation Growth Rate (2017-2019)
Figure France Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Oncology Ablation Growth Rate (2017-2019)
Figure UK Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Oncology Ablation Growth Rate (2017-2019)
Figure Russia Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Oncology Ablation Growth Rate (2017-2019)
Figure Italy Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Oncology Ablation Growth Rate (2017-2019)
Figure Rest of Europe Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Oncology Ablation Growth Rate (2017-2019)
Figure Asia-Pacific Oncology Ablation Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Oncology Ablation by Countries (2017-2019)
Figure Asia-Pacific Oncology Ablation Revenue (Million USD) by Countries (2017-2019)
Figure China Oncology Ablation Growth Rate (2017-2019)
Figure China Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Oncology Ablation Growth Rate (2017-2019)
Figure Japan Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Oncology Ablation Growth Rate (2017-2019)
Figure Korea Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Oncology Ablation Growth Rate (2017-2019)
Figure India Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Oncology Ablation Growth Rate (2017-2019)
Figure Southeast Asia Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Oncology Ablation Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Oncology Ablation Growth Rate (2017-2019)
Figure South America Oncology Ablation Revenue and Growth Rate (2017-2019)
Figure South America Oncology Ablation by Countries (2017-2019)
Figure South America Oncology Ablation Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Oncology Ablation Growth Rate (2017-2019)
Figure Brazil Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Oncology Ablation Growth Rate (2017-2019)
Figure Argentina Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Oncology Ablation Growth Rate (2017-2019)
Figure Columbia Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Oncology Ablation Growth Rate (2017-2019)
Figure Rest of South America Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Oncology Ablation Growth Rate (2017-2019)
Figure Middle East and Africa Oncology Ablation Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Oncology Ablation by Countries (2017-2019)
Figure Middle East and Africa Oncology Ablation Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Oncology Ablation Growth Rate (2017-2019)
Figure Saudi Arabia Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Oncology Ablation Growth Rate (2017-2019)
Figure United Arab Emirates Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Oncology Ablation Growth Rate (2017-2019)
Figure Egypt Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Oncology Ablation Growth Rate (2017-2019)
Figure Nigeria Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Oncology Ablation Growth Rate (2017-2019)
Figure South Africa Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Oncology Ablation Growth Rate (2017-2019)
Figure Turkey Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Oncology Ablation Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Oncology Ablation Revenue (Millions USD) and Growth Rate (2017-2019)
Table Philips Oncology Ablation Financial Overview
Table Biomedical Oncology Ablation Financial Overview
Table Medtronic Oncology Ablation Financial Overview
Table AngioDynamics Oncology Ablation Financial Overview
Table Medtronic Oncology Ablation Financial Overview
Table Ethicon Oncology Ablation Financial Overview
Table ZenoMed Oncology Ablation Financial Overview
Figure Global Oncology Ablation Revenue (Millions USD) and Growth Rate (2019-2027)
Table Oncology Ablation Market Forecast by Regions (2019-2027)
Figure North America Oncology Ablation Market Forecast (2019-2027)
Figure United States Oncology Ablation Market Forecast (2019-2027)
Figure Canada Oncology Ablation Market Forecast (2019-2027)
Figure Mexico Oncology Ablation Market Forecast (2019-2027)
Figure Europe Oncology Ablation Market Forecast (2019-2027)
Figure Germany Oncology Ablation Market Forecast (2019-2027)
Figure France Oncology Ablation Market Forecast (2019-2027)
Figure UK Oncology Ablation Market Forecast (2019-2027)
Figure Russia Oncology Ablation Market Forecast (2019-2027)
Figure Italy Oncology Ablation Market Forecast (2019-2027)
Figure Rest of Europe Oncology Ablation Market Forecast (2019-2027)
Figure Asia-Pacific Oncology Ablation Market Forecast (2019-2027)
Figure China Oncology Ablation Market Forecast (2019-2027)
Figure Japan Oncology Ablation Market Forecast (2019-2027)
Figure Korea Oncology Ablation Market Forecast (2019-2027)
Figure India Oncology Ablation Market Forecast (2019-2027)
Figure Southeast Asia Oncology Ablation Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Oncology Ablation Market Forecast (2019-2027)
Figure South America Oncology Ablation Market Forecast (2019-2027)
Figure Brazil Oncology Ablation Market Forecast (2019-2027)
Figure Argentina Oncology Ablation Market Forecast (2019-2027)
Figure Columbia Oncology Ablation Market Forecast (2019-2027)
Figure Rest of South America Oncology Ablation Market Forecast (2019-2027)
Figure Middle East and Africa Oncology Ablation Market Forecast (2019-2027)
Figure Saudi Arabia Oncology Ablation Market Forecast (2019-2027)
Figure United Arab Emirates Oncology Ablation Market Forecast (2019-2027)
Figure Egypt Oncology Ablation Market Forecast (2019-2027)
Figure Nigeria Oncology Ablation Market Forecast (2019-2027)
Figure South Africa Oncology Ablation Market Forecast (2019-2027)
Figure Turkey Oncology Ablation Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Oncology Ablation Market Forecast (2019-2027)
Figure Global Oncology Ablation Forecast by Product Type (2019-2027)
Figure Global Oncology Ablation Market Share Forecast by Product Type (2019-2027)
Figure Global Oncology Ablation Forecast by Product Type (2019-2027)
Figure Global Oncology Ablation Forecast by Applications (2019-2027)
Figure Global Oncology Ablation Market Share Forecast by Applications (2019-2027)
Figure Global Oncology Ablation Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|